With respect to any information in the government's possession regarding Alzheimer’s disease and related dementias (ADRDs) in Canada: (a) how many Canadians are impacted by ADRDs today, (i) what is the incidence and prevalence in Canada, broken down by gender and by 5-year cohort above 65 years of age, (ii) what is the average age of onset, (ii) what is the average time from diagnosis to requiring informal caregiving, (iii) what is the average time from diagnosis to requiring formal caregiving; (b) how many Canadians are currently in hospital, as a result of having ADRDs, (i) what are the benefits and risks of having people with ADRDs in regular hospital care, (ii) do people with ADRDs get the care they need in hospital care and if not, why not; (c) how do the number of hospitalizations compare for older adults with ADRDs than for age-matched older adults without ADRDs, (i) how do clinical outcomes compare for hospitalized people with ADRDs than for age-matched older adults without ADRDs; (d) what is the average cost of an acute care bed in hospital compared with the cost of a bed in long-term care; (e) what is the average length of time people with ADRDs spend in fully dependent care, and how does this length of time compare with other conditions, including, but not limited to, cardiovascular disease and cancer, (i) how does this length of time impact the health economics of ADRDs; (f) how many Canadians are caregivers to people with ADRDs, (i) what is the average length of time (in years) caregivers provide to people with ADRDs, both informally and within formal care, (ii) what is the annual estimated value of the care caregivers provide for those with ADRDs in Canada, (iii) how many Canadian caregivers suffer stress, illness, or economic hardship as a result of caregiving, (iv) what are the estimated economic costs to the health care and social care systems; (g) what training do medical students and practising family physicians receive to ensure dementia is detected before it reaches a critical level; (h) do best practices exist for people with ADRDs, (i) how does care vary from one province and territory to another, and from one facility to another; (i) what research and studies has the government done, and what funding has it given following (i) the World Health Organization and Alzheimer’s Disease International report, “Dementia: A Public Health Priority”, and the Alzheimer Society of Canada’s report, “Rising Tide: The Impact of Dementia on Canadian Society”, (ii) what are the dates, results, recommendations, and funding amounts; (j) what is done by the government to (i) promote a dementia-friendly society, (ii) make ADRDs a national public health and social care priority, (iii) improve public and professional attitudes to, and understanding of, ADRDs, (iv) replicate some of the evidence-based approaches and solutions already adopted by countries to tackle ADRDs, (v) prioritize research, (vi) raise awareness about prevention, (vii) promote early diagnosis and management, (viii) strengthen workforce training and capacity, (ix) implement responsive care and health service delivery, especially for caregivers; (k) what research and studies has the government done, and what funding has it given regarding the need to work with the provinces, territories and stakeholders to develop a community-based dementia framework, designed to keep persons with dementia safely at home for as long as possible, (i) what are the dates, results, recommendations, and funding amounts; (l) what research, studies, funding has the government devoted to how a community-based dementia strategy would impact (i) emergency department overcrowding, (ii) hospitalizations, (iii) Alternative Level of Care rates, (iv) long-term bed placement, (v) freeing-up of hospital beds, (vi) hospital overcrowding, (vii) wait times, (viii) number of new nursing homes that would need to be built, (ix) quality of life for those with ADRDs, (x) costs; (m) how are ADRDs expected to increase over the next 20 years, (i) what are the estimated costs to families and the health care system; (n) how are healthcare costs and healthcare resources expected to increase over the next 20 years given the rapidly increasing numbers of persons with ADRDs; (o) what research, studies, funding has the government devoted to developing a pan-Canadian brain strategy to address (i) neurodevelopmental brain conditions, (ii) neurodegenerative brain conditions, (iii) brain and spinal cord injury, (iv) what are the dates of any studies, results, recommendations, and funding amounts; (p) what research, studies, and funding has the government given to developing a pan-Canadian dementia strategy, (i) what are the dates of any studies, results, recommendations, and funding amounts; (q) what consultations has the government undertaken with respect to a pan-Canadian brain strategy, (i) how many stakeholders are calling for such a strategy, (ii) how many Canadians and their families do each of the identified stakeholders represent; and (r) what consultations has the government undertaken with respect to a pan-Canadian dementia strategy, (i) how many stakeholders are calling for such a strategy, (ii) how many Canadians and their families do each of the identified stakeholders represent?
In the House of Commons on October 29th, 2014. See this statement in context.